Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer is a research paper published in The Oncologist (2020). On theSindex it has a DataRank of 0. It has been cited 58 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
DOD Prostate Cancer Research Program
Grant: W81XWH-16-PCRP-CCRSA
DOD Prostate Cancer Research Program
Grant: W81XWH2010079
National Institutes of Health
Grant: P30 CA006973
National Institutes of Health
Grant: 2T32CA009071
NCATS NIH HHS
Grant: UL1 TR002538
NCI NIH HHS
Grant: T32 CA009071
National Institutes of Health
Grant: 5T32CA009071-08
ONCOLOGY: CHEMOTHERAPY, IMMUNOLOGY, BIOLOGY
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
FWCI
2.43
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals